Why the study?
Are increased ADMA plasma levels associated with unfavorable pulmonary hemodynamics and worse outcomes in patients with idiopathic pulmonary arterial hypertension?
Population
Patients with idiopathic pulmonary arterial hypertension (IPAH)
Design
Cohort
Authors
Loading...
ADMA may aid IPAH prognostication; leaves open whether measurement improves risk stratification or guides therapy.
Are increased ADMA plasma levels associated with unfavorable pulmonary hemodynamics and worse outcomes in patients with idiopathic pulmonary arterial hypertension?
Increased ADMA plasma levels may serve as a biomarker for unfavorable hemodynamics and worse clinical outcomes in patients with idiopathic pulmonary arterial hypertension.
Kielstein et al. (2005) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: